These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8043237)

  • 61. [Cholestatic hepatitis caused by a combination of amoxicillin and clavulanic acid (Augmentin)].
    van den Broek JW; Buennemeyer BL; Stricker BH
    Ned Tijdschr Geneeskd; 1988 Aug; 132(32):1495-7. PubMed ID: 3173514
    [No Abstract]   [Full Text] [Related]  

  • 62. [Cholestatic hepatitis caused by amoxicillin-clavulanic acid].
    Rodríguez M; Sleiman H; Suárez A; Rodrigo L
    Med Clin (Barc); 1991 Jan; 96(2):78. PubMed ID: 2023483
    [No Abstract]   [Full Text] [Related]  

  • 63. [Usefulness of an amoxicillin/clavulanic-acid combination in respiratory tract infection: bacterial resistance and antibiotic therapy].
    Caramia M; Taddei G; Nobilini A
    Minerva Pediatr; 1990; 42(1-2):29-34. PubMed ID: 2186263
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A pharmacoeconomic comparison of amoxicillin/clavulanate and cefpodoxime proxetil in the treatment of acute otitis media.
    Landholt TF; Kotschwar TR
    Clin Ther; 1994; 16(2):327-33; discussion 271-2. PubMed ID: 8062326
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bacteriologic failure of amoxicillin-clavulanate in treatment of acute otitis media caused by nontypeable Haemophilus influenzae.
    Patel JA; Reisner B; Vizirinia N; Owen M; Chonmaitree T; Howie V
    J Pediatr; 1995 May; 126(5 Pt 1):799-806. PubMed ID: 7752010
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Hepatotoxicity caused by amoxicillin-clavulanic acid].
    Reñe JM; Buenestado J; Piñol MC
    Gastroenterol Hepatol; 1997; 20(6):337-8. PubMed ID: 9296855
    [No Abstract]   [Full Text] [Related]  

  • 67. Cholestatic hepatitis associated with clavulanic acid.
    Ryan J; Dudley F
    Gut; 1992 Nov; 33(11):1583. PubMed ID: 1452090
    [No Abstract]   [Full Text] [Related]  

  • 68. [Treatment of spontaneous ascites fluid infection with amoxicillin and clavulanic acid].
    Zeni F; Tardy B; Page Y; Comtet C; Billard JL; Bertrand JC
    Presse Med; 1991 Oct; 20(31):1511-2. PubMed ID: 1835048
    [No Abstract]   [Full Text] [Related]  

  • 69. A clinical evaluation of clavulanate-potentiated amoxycillin in the management of moderate to severe respiratory tract infections.
    Anyanwu CH; Umeh BU
    J Int Med Res; 1988; 16(3):210-5. PubMed ID: 3044873
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
    Lim TK
    Singapore Med J; 1997 Mar; 38(3):139. PubMed ID: 9269388
    [No Abstract]   [Full Text] [Related]  

  • 71. Clinical efficacy of amoxycillin/clavulanate in laparoscopically confirmed salpingitis.
    Obwegeser J; Kunz J; Wüst J; Schär G; Steiner R; Büchi W
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():165-76. PubMed ID: 2532640
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Clarithromycin versus amoxicillin-clavulanic acid in the treatment of acute maxillary sinusitis in adults].
    Géhanno P; Barry B; Chauvin JP; Hazebroucq J
    Pathol Biol (Paris); 1996 Apr; 44(4):293-7. PubMed ID: 8763594
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Controlled prospective study of oral amoxycillin/clavulanate vs ciprofloxacin in acute exacerbations of chronic bronchitis.
    Schmidt EW; Zimmermann I; Ritzerfeld W; Voss E; Ulmer WT
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():185-93. PubMed ID: 2691479
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid.
    García Rodríguez LA; Stricker BH; Zimmerman HJ
    Arch Intern Med; 1996 Jun; 156(12):1327-32. PubMed ID: 8651842
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Amoxycillin/clavulanic acid ('Augmentin') compared with a combination of aminopenicillin, aminoglycoside and metronidazole in the treatment of pelvic inflammatory disease.
    Cirau-Vigneron N; Barrier J; Becue J; Chartier M; Giraud JR; Landes P; Leng J; Raudrant D; Reme JM
    Pharmatherapeutica; 1989; 5(5):312-9. PubMed ID: 2664816
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Augmentin for urinary tract infections.
    Bailey RR
    N Z Med J; 1992 Mar; 105(929):90. PubMed ID: 1545949
    [No Abstract]   [Full Text] [Related]  

  • 77. [Acute pancreatitis associated with hepatotoxicity induced by amoxicillin-clavulanic acid].
    Galindo C; Buenestado J; Reñé JM; Piñol MC
    Rev Esp Enferm Dig; 1995 Aug; 87(8):597-600. PubMed ID: 7577112
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Amoxycillin/clavulanic acid induced cholestasis.
    Michielsen PP; Van Outryve MJ; Van Marck EA; De Maeyer MH; Pelckmans PA; Van Maercke YM
    J Hepatol; 1990 Nov; 11(3):392. PubMed ID: 2290034
    [No Abstract]   [Full Text] [Related]  

  • 79. Intrahepatic cholestasis without hepatitis induced by amoxycillin/clavulanic acid.
    Pedro-Botet J; Supervía A; Barranco C; Solá R; Bruguera M
    J Clin Gastroenterol; 1996 Sep; 23(2):137-8. PubMed ID: 8877644
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sensitization to amoxycillin in Augmentin.
    Kennedy C; Stolz E; van Joost T
    Contact Dermatitis; 1989 Apr; 20(4):313-4. PubMed ID: 2752748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.